Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF (Record no. 30585094)

MARC details
000 -LEADER
fixed length control field 02396 a2200721 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518083144.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202007s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1474-5488
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S1470-2045(20)30062-0
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Dummer, Reinhard
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200706
245 00 - TITLE STATEMENT
Title Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Lancet. Oncology
Date of publication, distribution, etc. 03 2020
300 ## - PHYSICAL DESCRIPTION
Extent 358-372 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Neoplasm
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Imidazoles
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Metastasis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oximes
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proto-Oncogene Proteins B-raf
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridones
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidinones
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Salvage Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Skin Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brase, Jan C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garrett, James
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Campbell, Catarina D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gasal, Eduard
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Squires, Matthew
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gusenleitner, Daniel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Santinami, Mario
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Atkinson, Victoria
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mandalà, Mario
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chiarion-Sileni, Vanna
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Flaherty, Keith
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Larkin, James
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Robert, Caroline
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kefford, Richard
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kirkwood, John M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hauschild, Axel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schadendorf, Dirk
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Long, Georgina V
773 0# - HOST ITEM ENTRY
Title The Lancet. Oncology
Related parts vol. 21
-- no. 3
-- p. 358-372
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S1470-2045(20)30062-0">https://doi.org/10.1016/S1470-2045(20)30062-0</a>
Public note Available from publisher's website

No items available.